10-K: Tilray Brands Files 2026 Annual Report on Form 10-K

Tilray Brands, Inc. has filed its Annual Report on Form 10-K for the fiscal year ended May 31, 2026, detailing its financial performance, strategic initiatives, and risk factors across its cannabis, beverage, distribution, and wellness segments.

Summary

• Tilray Brands, Inc. (Tilray) has filed its Form 10-K for the fiscal year ended May 31, 2026, providing a comprehensive overview of its operations and financial condition.
• The company operates across four segments: Beverage, Cannabis, Distribution, and Wellness, with a global presence in Canada, the United States, Europe, Australia, and Latin America.
• Key strategic initiatives include expanding its global beverage platform through acquisitions like BrewDog, focusing on brand building, product innovation in cannabis, and optimizing global operations for cost reduction and cash generation.
• The filing details significant acquisitions in the beverage sector, including BrewDog and Lyphe Group, and outlines the company's strategy to leverage its brand portfolio and infrastructure for profitable growth.
• Tilray reported total net revenue of $915.5 million for the fiscal year ended May 31, 2026, an increase of 11% from the prior year, driven by growth across its segments, particularly Distribution and International Cannabis.
• The company incurred a net loss of $105.2 million for the fiscal year ended May 31, 2026, an improvement from the net loss of $2.18 billion in the prior year, which was impacted by significant impairment charges.
• The report highlights ongoing efforts to manage costs, optimize operations, and navigate a complex regulatory environment, particularly in the evolving U.S. cannabis market.
• Forward-looking statements indicate a focus on continued growth, profitability, and long-term shareholder value, while acknowledging risks related to regulatory changes, competition, and macroeconomic conditions.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this filing as cautiously optimistic, with strong revenue growth and improved operational metrics, but tempered by a continued net loss and significant ongoing risks in the highly regulated cannabis and beverage markets.

Positives

• Total net revenue increased by 11% to $915.5 million for the fiscal year ended May 31, 2026.
• The Beverage segment saw a 6% increase in net revenue to $254.0 million, boosted by the BrewDog acquisition.
• The Distribution segment revenue grew by 21% to $327.2 million.
• International cannabis revenue increased by 34% to $84.9 million, with significant growth in Germany and Poland.
• Adjusted EBITDA increased by 11% to $61.1 million.
• Gross margin in the Cannabis segment remained strong at 40%.
• The company completed several strategic acquisitions in the beverage sector, including BrewDog and Lyphe Group, to expand its global reach and brand portfolio.
• Tilray continues to lead in the Canadian cannabis market with the highest cannabis revenue in Canada.

Negatives

• The company reported a net loss of $105.2 million for the fiscal year ended May 31, 2026.
• Beverage segment gross margin decreased to 36% from 39% due to industry challenges, lower volumes, and margin-focused actions.
• Canadian adult-use cannabis revenue saw a 4% decline in the whole flower category due to cultivation strain rotation and inventory redirection to international markets.
• Wholesale cannabis revenue decreased by 60% to $7.3 million due to strategic product redirection to other markets.
• The company incurred significant operating expenses, including $203.6 million in general and administrative costs.
• Stock-based compensation expense increased significantly to $45.9 million due to performance-based awards.
• The company faces ongoing litigation, including a securities class action related to past acquisitions.
• The company has a history of net losses and may not achieve or maintain profitability in the future.

Risks

• The company's business is highly dependent on maintaining regulatory approvals, licenses, and permits across multiple jurisdictions, and changes in cannabis, hemp, or other applicable laws could materially adversely affect operations and strategy.
• Evolving international regulations, including import/export restrictions and delays, may limit the ability to expand and operate globally.
• Significant competition exists across cannabis and beverage businesses, including from illicit market participants and large, well-capitalized competitors.
• The beverage business is subject to changing consumer preferences, reliance on third-party distributors, and strong competitive pressures that could reduce sales and margins.
• Operations depend on key facilities, supply chains, and agricultural production, which are subject to risks such as natural disasters, crop failure, supply disruption, and increases in input costs.
• Products may be subject to recalls, contamination, product liability claims, or adverse health effects, and negative publicity may harm consumer demand and reputation.
• Cybersecurity incidents, information technology failures, or data privacy breaches could disrupt operations, result in financial losses, and expose the company to liability.
• The market price of common stock is highly volatile, and the capital structure, including convertible securities and future equity issuances, may result in dilution or limit strategic flexibility.

Future Outlook

Tilray Brands aims to drive revenue growth, achieve industry-leading profitability, and build sustainable long-term shareholder value by focusing on brand development, product innovation, and operational efficiencies. The company expects to leverage its expanded global beverage platform and its position in the cannabis market to capitalize on future growth opportunities, including potential U.S. federal legalization.

Management Comments

• Our overall strategy is to leverage our brands, infrastructure, expertise and capabilities to drive revenue growth in the industries and channels in which we compete, achieve industry-leading, profitability and build sustainable, long-term shareholder value.
• In addition, we are relentlessly focused on managing our cost structure and expenses in order to expand margins and maintain our strong financial position.
• We believe that Tilray remains uniquely well-positioned to maintain and gain significant market share in the markets in which we participate.
• We continue to believe that these recent efforts to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act represent meaningful progress toward broader cannabis reform and have the potential to accelerate clinical research, broaden patient access, and support the development of a regulated, science-driven medical cannabis market in the United States.

Industry Context

StockSavvy.ai notes that Tilray's filing reflects a dynamic period for the cannabis and beverage industries, marked by significant M&A activity, evolving consumer preferences, and ongoing regulatory developments, particularly concerning cannabis rescheduling in the U.S. The company's diversification strategy into the beverage sector, exemplified by the BrewDog acquisition, positions it to navigate these complex market trends.

Comparison to Industry Standards

• Tilray Brands is the 4th largest craft brewer in the United States according to the Brewers Association 2025 U.S. Craft Brewing Industry Figures Report.
• In Canada, Tilray continues to lead the Canadian cannabis market with the highest cannabis revenue.
• Manitoba Harvest business is a leader in the hemp-based food category in the U.S.
• The company's international cannabis operations are expanding into markets like Germany, which is the largest medical cannabis market in Europe.
• The company's beverage portfolio includes 18 craft beverage brands, competing with numerous domestic and international beverage companies.
• The cannabis industry globally is still in its early stages of development, with countries like Germany and Australia showing significant market maturation.
• The company's focus on EU-GMP certified facilities in Portugal and Germany aligns with the stringent quality standards required for international medical cannabis markets.
• The company's strategy to integrate acquired beverage businesses and optimize its cost structure is a common approach in the consolidating craft beverage industry.

Legal Proceedings

• Aphria Inc. Securities Litigation (New York, United States): A putative securities class action claims misrepresentation regarding LATAM Assets. The court denied motions to dismiss, and a class was certified. Fact discovery is complete, and the company is vigorously defending the claims.
• MMIRF, LLC v. Tilray Brands, Inc., et al: Plaintiff alleges breach of fiduciary duty and related claims stemming from transactions involving MedMen Enterprises, Inc. The plaintiff seeks damages in excess of $1.0 billion. Tilray intends to vigorously defend against these claims.
• Fotmer Corporation S.A. v. Tilray Brands Inc. et al: An arbitration award ordered Tilray to pay Fotmer $1,233 for alleged breaches of a purchase agreement. Tilray has asserted claims against Fotmer in German court, seeking $2,250 and has received a judgment in its favor, which it is pursuing enforcement for.

Related Party Transactions

• Benjamin Persofsky (son of Director Renah Persofsky) is employed as Senior Legal Counsel, earning $130,000 in FY2026.
• Garrett Simon (son of Director Irwin Simon) is employed in the beverage marketing group, earning $127,000 in FY2026.
• The company holds a 25% equity interest in Solana Life Group, S. de R.L., a Panamanian entity engaged in medical cannabis operations. No transactions occurred with this entity in FY2026.
• The company dissolved its membership interest in RIKI Ventures, LLC, receiving a termination fee of $77 in FY2026.

Stakeholder Impact

• Shareholders may experience continued stock price volatility due to market conditions and the company's capital structure.
• The company's focus on cost reduction and operational efficiency aims to improve profitability, potentially benefiting shareholders.
• Employees are subject to retention agreements, indicating management's focus on retaining key personnel.
• The company's global operations and acquisitions may impact employees in various regions, with potential integration challenges.
• Customers in the beverage and cannabis markets may see continued innovation and brand offerings.
• Creditors and debt holders are subject to the company's financial performance and its ability to meet debt obligations and covenants.

Next Steps

• Continue to integrate acquired beverage businesses, including BrewDog and Lyphe Group.
• Focus on improving profitability within the cannabis category by prioritizing higher-margin premium brands.
• Optimize cultivation footprint and supply chain to support demand across Canadian and international markets.
• Monitor and adapt to evolving regulatory landscapes, particularly in the U.S. cannabis market.
• Continue to manage cost structure and expenses to expand margins and maintain a strong financial position.
• Explore opportunities for new product development and entries into new geographies.
• Manage debt and capital structure to enhance financial flexibility.
• Continue to invest in marketing, promotion, and infrastructure of core brands.

Key Dates

Recommendation

While Tilray Brands shows positive revenue growth and improved Adjusted EBITDA, the continued net loss, significant impairment charges in the prior year, and ongoing risks in the highly regulated cannabis and beverage industries warrant a 'hold' recommendation. The company's strategic acquisitions and market leadership are positive, but the path to sustained profitability and the impact of regulatory changes require further monitoring.

Keywords

Tilray Brands, Form 10-K, Annual Report, Cannabis, Beverage, BrewDog Acquisition, Financial Results, SEC Filing